# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-22-008033
Filing Date
2022-04-01
Accepted
2022-04-01 16:00:11
Documents
6
Period of Report
2022-05-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM PRE 14A | atos20220303_pre14a.htm | PRE 14A | 308801
2 |  | atos20220303_pre14aimg001.jpg | GRAPHIC | 3759
3 |  | atos20220303_pre14aimg002.jpg | GRAPHIC | 3195
4 |  | atos20220303_pre14aimg003.jpg | GRAPHIC | 3759
5 |  | proxy1.jpg | GRAPHIC | 455974
6 |  | proxy2.jpg | GRAPHIC | 341707
| Complete submission text file | 0001437749-22-008033.txt |  | 1424004

Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35610 | Film No.: 22798085
SIC: 2834 Pharmaceutical Preparations